A significant shift in Canadian drug policy has occurred, as the authorities allow the use of psilocybin fungi for therapeutic treatment. Before this, these substances were strictly restricted, but a mounting body of evidence suggests they potentially offer benefits for emotional illnesses like depression. The new policy represents a major step tow